Gallium nitrate revisited

Seminars in Oncology

Volumn 30, Issue 2 SUPPL. 5, 2003, Pages 1-4

  Chitambar, Christopher R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GALLIUM NITRATE; GEMCITABINE; MELPHALAN; METHOTREXATE; PARATHYROID HORMONE; PHOSPHATE; PREDNISONE; TAXANE DERIVATIVE; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BONE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FOLLICULAR LYMPHOMA; HUMAN; HYPERCALCEMIA; LARGE CELL LYMPHOMA; LYMPHOMA; METASTASIS; MULTIPLE MYELOMA; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BONE AND BONES; GALLIUM; HUMANS; HYPERCALCEMIA; LYMPHOMA; NEOPLASMS;

EID: 0038824169     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00169-6     Document Type: Review

References (40)

1. Hart MM, Adamson RH: Antitumor activity and toxicity of salts of inorganic group 3a metals: Aluminum, gallium, indium, and thallium. Proc Natl Acad Sci U S A 68:1623-1626, 1971
2. Hart MM, Smith CF, Yancey ST, et al: Toxicity and antitumor activity of gallium nitrate and periodically related metal salts. J Natl Cancer Inst 47:1121-1127, 1971
3. Bedikian AY, Valdivieso M, Bodey GP, et al: Phase I clinical studies with gallium nitrate. Cancer Treat Rep 62: 1449-1453, 1978
4. Foster BJ, Clagett-Carr K, Hoth D, et al: Gallium nitrate: The second metal with clinical activity. Cancer Treat Rep 70: 1311-1319, 1986
5. Krakoff IH, Newman RA, Goldberg RS: Clinical toxicologic and pharmacologic studies of gallium nitrate. Cancer 44:1722-1727, 1979
6. Samson MK, Fraile RJ, Baker LH, et al: Phase I-II clinical trial of gallium nitrate (NSC-15200). Cancer Clin Trials 3:131-136, 1980
7. Warrell RP Jr, Coonley CJ, Straus DJ, et al: Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion. Cancer 51:1982-1987, 1983
8. Warrell RP, Bockman RS, Coonley CJ, et al: Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia. J Clin Invest 73: 1487-1490, 1984
9. Lamy O, Jenzer-Closuit A, Burckhardt P: Hypercalcaemia of malignancy: An underdiagnosed and undertreated disease. J Intem Med 250:73-79, 2001
10. Walls J, Ratcliffe WA, Howell A, et al: Response to intravenous bisphosphonate therapy in hypercalcemic patients with and without bone metastases: The role of parathyroid hormone-related protein. Br J Cancer 70: 169-172, 1994
11. Wimalawansa SJ: Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate. Cancer 73:2223-2230, 1994
12. Burtis WJ, Brady TG, Orloff JJ, et al: Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 322:1106-1112, 1990
13. Bertheault-Cvitkovic F, Armand J-P, Tubiana-Hulin M, et al: Randomized, double-blind comparison of pamidronate vs. gallium nitrate for acute control of cancer-related hypercalcemia. Presented at the 9th EORTC/NCI Symposium, Amsterdam, March 1996
14. Warrell RP, Murphy WK, Schulman P, et al: A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia. J Clin Oncol 9:1467-1475, 1991
15. Warrell RP, Israel R, Frisone M, et al: Gallium nitrate for acute treatment of cancer-related hypercalcemia. Ann Intern Med 108:669-674, 1988
16. Bockman RS, Boskey AL, Blumenthal NC, et al: Gallium increases bone calcium and crystallite perfection of hydroxyapatite. Calcif Tissue Int 39: 376-381, 1986
17. Repo MA, Bockman RS, Betts F, et al: Effect of gallium on bone mineral properties. Calcif Tissue Int 43:300-306, 1988
18. Bockman RS, Repo MA, Warrell RP Jr, et al: Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron x-ray microscopy. Proc Natl Acad Sci U S A 87:4149-4153, 1990
19. + ATPase by bonebound gallium. J Bone Miner Res 6: S127, 1991 (abstr)
20. Warrell RP Jr, Lovett D, Dilmanian FA, et al: Low-dose gallium nitrate for prevention of osteolysis in myeloma: Results of a pilot randomized study. J Clin Oncol 11:2443-2450, 1993
21. Warrell RP Jr, Alcock NW, Bockman RS: Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases. J Clin Oncol 5:292-298, 1987
22. Matkovic V, Apseloff G, Shepard DR, et al: Use of gallium to treat Paget's disease of bone: A pilot study. Lancet 335:72-75, 1990
23. Warrell RP Jr, Bosco B, Weinerman S, et al: Gallium nitrate for advanced Paget disease of bone: Effectiveness and dose-response analysis. Ann Intern Med 113:847-851, 1990
24. Bockman RS, Wilhelm F, Siris E, et al: A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone. J Clin Endocrinol Metab 80:595-602, 1995
25. Niesvizky R, Choy CG, Siegel D, et al: Extended survival in advanced-stage multiple myeloma patients treated with gallium nitrate. Leuk Lymphoma 43:603-605, 2002
26. Chitambar CR, Matthaeus WG, Antholine WE, et al: Inhibition of leukemic HL60 cell growth by transferrin-gallium: Effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea. Blood 72: 1930-1936, 1988
27. Hedley DW, Tripp EH, Slowiaczek P, et al: Effect of gallium on DNA synthesis by human T-cell lymphoblasts. Cancer Res 48:3014-3018, 1988
28. Chitambar CR, Narasimhan J, Guy J, et al: Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells. Cancer Res 51:6199-6201, 1991
29. Ul-Haq R, Werely JP, Chitambar CR: Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. Exp Hematol 28:428-432, 1995
30. Berggren MM, Burns LA, Abraham RT, et al: Inhibition of protein tyrosine phosphatase by the antitumor agent gallium nitrate. Cancer Res 53:1862-1866, 1993
31. Warrell RP Jr, Danieu L, Coonley CJ, et al: Salvage chemotherapy of advanced lymphoma with investigational drugs: Mitoguazone, gallium nitrate, and etoposide. Cancer Treat Rep 71:47-51, 1987
32. Chitambar CR, Zahir SA, Ritch PS, et al: Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma. Am J Clin Oncol 20:173-178, 1997
33. Genta Incorporated, Berkeley Heights, NJ: A phase II multicenter study of gallium nitrate in patients with relapsed or refractory non-Hodgkin's lymphoma. Protocol GGN202
34. Crawford ED, Saiers JH, Baker LH, et al: Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study. Urology 38:355-357, 1991
35. Seidman AD, Scher HI, Heinemann MH, et al: Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer 68:2561-2565, 1991
36. Seligman PH, Crawford ED: Treatment of advanced transitional cell carcinoma of the bladder with continuousinfusion gallium nitrate. J Natl Cancer Inst 83:157-159, 1991
37. Einhorn LH, Roth BJ, Ansari R, et al: Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma. J Clin Oncol 12:2271-2276, 1994
38. Dreicer R, Propert KJ, Roth BJ, et al: Vinblastine, ifosfamide, and gallium nitrate - An active new regimen in patients with advanced carcinoma of the urothelium: A phase II trial of the Eastern Cooperative Oncology Group (E5892). Cancer 79:110-114, 1997
39. Bernstein LR: Mechanisms of therapeutic activity for gallium. Pharmacol Rev 50:665-682, 1998
40. Collery P, Keppler B, Madoulet C, et al: Gallium in cancer treatment. Crit Rev Oncol Hematol 42:283-296, 2002